Physician profile
Robert M Palmer
NPI 1558380873
$3,615.38
in general payments reported to CMS, 2019-2025
29 companies · $613 in 2025
The $613 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $202 · 2021: $302 · 2022: $211 · 2023: $1,671 · 2024: $57.55 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,688 · Food and Beverage: $654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,687.53 |
| Food and Beverage | $654.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,813.52 | 2019-2025 | Da Vinci Surgical System |
| Globus Medical, INC. | $394.50 | 2025 | Excelsius Gps |
| Inari Medical, INC. | $206.04 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Smith+Nephew, INC. | $180.84 | 2019-2025 | Stravix |
| Tela Bio, INC. | $167.64 | 2019-2024 | Ovitex 2s |
| Allergan, INC. | $122.16 | 2020 | |
| Cook Medical LLC | $89.53 | 2019-2023 | Hemospray |
| Takeda Pharmaceuticals U.S.A., INC. | $78.22 | 2020-2023 | Gattex |
| Kowa Pharmaceuticals America, INC. | $55.08 | 2022-2023 | Seglentis |
| Braintree Laboratories, INC. | $49.62 | 2021-2022 | |
| Heron Therapeutics, INC. | $43.45 | 2022-2023 | Zynrelef |
| Acera Surgical, INC. | $40.33 | 2024 | Restrata Wound Matrix |
| Davol INC. | $33.54 | 2021-2023 | Arista Ah Flexitip |
| Shire North American Group INC | $33.53 | 2019 | |
| Acell, INC. | $31.94 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $30.58 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Novartis Pharmaceuticals Corporation | $27.86 | 2022 | |
| Medtronic, INC. | $24.00 | 2021 | |
| Avanos Medical | $23.29 | 2025 | On-Q Pump and Accessories |
| Stryker Corporation | $19.56 | 2021 | |
| Mimedx Group, INC. | $18.96 | 2025 | |
| Baxter Healthcare | $18.54 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.44 | 2019 | |
| Abbott Laboratories | $17.89 | 2019 | |
| Innocoll Pharmaceuticals Limited | $16.82 | 2021 | |
| Cardinal Health 414 LLC | $16.21 | 2020 | |
| Integra Lifesciences Corporation | $16.00 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.69 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $13.60 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.